New PET scan could slash radiation exposure for tumor patients

NCT ID NCT07284589

Recruiting now Diagnosis Sponsor: Akiva Mintz Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new PET imaging method that uses much less radiation to find neuroendocrine tumors. About 200 healthy volunteers and people with these tumors will get an injection of a radioactive tracer and be scanned on a high-sensitivity PET machine. The goal is to see if the scan can use 10 to 100 times less radiation than current standards while still producing clear images.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 68Ga-Dotatate (radioactive tracer)
What this could lead to: If successful, this could make PET scans for neuroendocrine tumors much safer by using 10-100 times less radiation, while still getting clear images.
What could go wrong: This is a Phase 2 trial focused on image quality, not on treatment outcomes. The new technique may not work as well in all patients or may not improve detection enough to replace current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY CONTROLS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm neuroendocrine neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY CONTROLS HEALTHY VOLUNTEERS NEUROENDOCRINE (NE) TUMORS

Contacts and locations

Locations

Nuclear Imaging Institute
RECRUITING

Englewood, New Jersey, 07631, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.